II. Epidemiology
- Patients with VTE and no risk Factors under age 40 years: 28%
III. Pathophysiology: Virchow's Triad
- VTE is caused by at least one of three dysfunctions
- Hypercoagulability
- Blood Flow alterations
- Endothelial injury or dysfunction
IV. Risk Factors: Venous Thromboembolism By Strength of Risk
- Strong Risk Factors (Odds Ratio >10)
- Hip Fracture (or leg Fracture)
- Total Hip Arthroplasty (THA)
- Total Knee Arthroplasty (TKA)
- Major general surgery (within last 3 months)
- Major Trauma (within last 3 months)
- Spinal Cord Injury
- Intermediate Risk Factors (Odds Ratio 2-9)
- Arthroscopic knee surgery
- Central venous catheters (e.g. femoral line)
- Active Cancer
- Chemotherapy
- Chronic Heart Failure
- Respiratory Failure
- Hormone Replacement Therapy
- Oral Contraceptives with Estrogen
- Malignancy
- Cerebrovascular Accident with Hemiplegia
- Pregnancy or postpartum
- Thrombophilia
- Prior Venous Thromboembolism
- Weak Risk Factors(Odds Ratio <2)
- Bed rest >3 days
- Car or air travel >8 hours (or other prolonged sitting)
- Advanced age
- Laparoscopic surgery
- Morbid Obesity (BMI >40)
- Varicose Veins
- Testosterone Replacement (esp. first 3 months of use)
- Male Gender
- References
V. Risk Factors: Initial Venous Thromboembolism by chronicity
- Major transient risks
- Hospitalization >3 days with limited mobility
- Hospitalization for COVID-19 Management
- Immobilization for >3 days
- Plaster cast immobilization
- Bed rest
- Surgery under general Anesthesia >30 minutes
- Trauma
- Minor transient risks
- Hospitalization <3 days
- Prolonged travel >2 hours (risk increases 18% for every 2 hours traveled)
- Highest risk with air travel >4 hours or car travel >12 hours within a 24 hours period
- Pregnancy
- Estrogen in Oral Contraceptives or other hormonal products or Testosterone Replacement
- Major risk factor preceding VTE by 1 to 3 months
- Chronic or Persistent Risks
- Collagen vascular disease (e.g. Systemic Lupus Erythematosus, Rheumatoid Arthritis)
- Antiphospholipid Antibody Syndrome
- Adult low body weight <110 pounds or <50 kg
- Adult high body weight > 264 lb (120 kg) or BMI >= 30 kg/m2
- Chronic immobilization
- Chronic infectious disease
- Inflammatory Bowel Disease
- Male gender
- Heart Failure
- Cancer
- Myeloproliferative disorders
- Nephrotic Syndrome
- Recurrent Pregnancy Loss
VI. Risk Factors: Recurrent Thromboembolism after stopping Anticoagulants (Relative Risk)
- Metastatic cancer (6-9)
- Stage 4 Prostate Cancer has the highest recurrence rates
- Factor VIII >200 IU/dl (6)
- Non-metastatic Cancer (3)
- Brain Cancer
- Myeloproliferative Disorders
- Ovarian Cancer
- Lung Cancer
- Non-rectal Gastrointestinal cancer
- Antiphospholipid Antibody Syndrome (2.5)
- D-Dimer increase after acute therapy completed (2.2)
- Persistent risk factors - see above (2)
- Idiopathic VTE (2)
- Protein C,Protein S and Antithrombin deficiency (1.8)
- Prothrombin mutation - G20210A (1.7)
- Homozygous for Factor V Leiden (1.6)
- Second VTE (1.5)
- Proximal DVT has a 4 fold higher risk of recurrence than distal DVT
- Central Pulmonary Embolism has higher risk of recurrence than peripheral PE
- Mild Hyperhomocysteinemia (0.9)
- Transient risk factors (0.5)
- Kearon (2008) Chest 133(6 suppl):454S [PubMed]
VII. Risk Factors: Venous Stasis
- Hospitalization (Relative Risk: 100)
- Prolonged immobility
- Long leg Fracture or other limb immobilization
- Paralysis
-
Varicose Veins
- High risk for DVT in surgery without DVT Prophylaxis
- Obesity
- Cardiac Disease
-
May-Thurner Syndrome
- Compressed right iliac common artery (RICA) results in ileofemoral DVT
- Arterial variants of RICA predispose to compression
- Resulting RICA pressure against lumbar bony Vertebrae resulting in bony spur formation
- Spurs and RICA compress iliac veins, resulting in DVT (esp. Left ileofemoral DVT)
- More common in women (RR 2)
- Responsible for 2 to 5% of DVTs (esp. females in their teens and twenties)
VIII. Risk Factors: Hypercoagulable
-
Hypercoagulable state
- See Thrombophilia
- Inherited cause found in up to one third of DVT cases
- Prior Deep Vein Thrombosis (DVT)
- Medications
- Increased Estrogen
- Oral Contraceptive or Estrogen Replacement
- Pregnancy
- Tamoxifen (Nolvadex)
- Hydralazine
- Phenothiazines
- Procainamide
- Increased Estrogen
- Major Trauma
- Recent Surgery
-
Systemic Lupus Erythematosus
- Associated with Antiphospholipid Antibody Syndrome
- Venous Thromboembolism is a major cause of mortality in SLE
- Cancer (responsible for 20% of pulmonary emboli, and PE may be the cancer's presenting finding)
- Colon Cancer
- Ovarian Cancer
- Multiple Myeloma
- Consider evaluation for occult cancer in DVT
- Chemotherapy
- Inflammatory Bowel Disease
-
HIV Infection
- Associated with a 7% annual Incidence of DVT
- Primary Thrombophilia mechanism is via affects on Protein C and Protein S
- Opportunistic infection with associated endothelial damage also contributes to thrombosis risk
- Polycythemia
- Sickle Cell Anemia
- Nephrotic Syndrome
- History of thromboembolic disease
- Deep Venous Thrombosis
- Pulmonary Embolus
- Type A Blood
IX. Risk Factors: Intimal damage
- Local Trauma
- Surgery (Especially General and Orthopedic Surgery)
- General Anesthesia is an independent risk factor
- Consider DVT Prophylaxis
- Penetrating vessel injury
- Intravenous Drug Abuse
- Central Line Placement
- Especially femoral Central Line